Tyson Foods
TSN
51.70
-0.27
-0.52%
Tyson Foods
US · TSN
#1004 by market cap
Listed 1970
51.70
-0.27
-0.52%
Live - 5344 symbols - heartbeat 315s ago
· 2026-10-08 08:26
Pre-market
51.70
0.00%
After-hours
51.39
-0.60%
- Market cap
- 18.19B
- P/E (TTM)i
- 31.91
- P/Bi
- 1.01
- EPSi
- 1.33
- Div yieldi
- 3.93%
- 52W posi
- 15%
Reader sentiment
Are you bullish or bearish on TSN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.03, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +2.12% YoY
Margins
- Gross margin
- 6.54%
- Operating margin
- 2.65%
- Net margin
- 0.87%
Key ratios & quality
- Enterprise valuei
- 25.79B
- Altman Z-Scorei
- 3.03
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 40.05B | 42.41B | 43.19B | 47.05B | 53.28B | 52.88B | 53.31B | 54.44B |
| Gross profit | 5.10B | 5.02B | 5.38B | 6.53B | 6.67B | 2.63B | 3.63B | 3.56B |
| Selling & admin expenses | 2.13B | 2.25B | 2.38B | 2.13B | 2.26B | 2.25B | 2.22B | 2.12B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 2.97B | 2.77B | 3.01B | 4.40B | 4.41B | 386.00M | 1.41B | 1.44B |
| Pretax profit | 2.68B | 2.37B | 2.66B | 4.04B | 4.15B | -678.00M | 1.09B | 769.00M |
| Tax | -291.00M | 381.00M | 593.00M | 981.00M | 900.00M | -29.00M | 270.00M | 262.00M |
| Net profit | 2.97B | 1.99B | 2.07B | 3.06B | 3.25B | -649.00M | 822.00M | 507.00M |
| Basic EPS | 8 | 6 | 6 | 9 | 9 | -2 | 2 | 1 |
| Diluted EPS | 8.04 | 5.40 | 5.64 | 8.34 | 8.92 | -1.87 | 2.25 | 1.33 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 13.07B | 13.88B | 13.86B | 14.31B | 13.65B | 13.87B |
| Gross profit | 600.00M | 1.14B | 726.00M | 808.00M | 962.00M | 921.00M |
| Selling & admin expenses | 500.00M | 538.00M | 568.00M | 506.00M | 527.00M | 559.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 100.00M | 603.00M | 158.00M | 302.00M | 435.00M | 362.00M |
| Pretax profit | 30.00M | 193.00M | 68.00M | 127.00M | 359.00M | 266.00M |
| Tax | 16.00M | 124.00M | 10.00M | 37.00M | 95.00M | 80.00M |
| Net profit | 14.00M | 69.00M | 58.00M | 90.00M | 264.00M | 186.00M |
| Basic EPS | 0 | 0 | 0 | 0 | 1 | 1 |
| Diluted EPS | 0.02 | 0.17 | 0.13 | 0.24 | 0.73 | 0.52 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 5.69B | 6.99B | 7.60B | 9.82B | 9.63B | 8.72B | 9.75B | 9.92B |
| Cash & ST investments | 270.00M | 484.00M | 1.42B | 2.51B | 1.03B | 573.00M | 1.72B | 1.23B |
| Inventory | 3.51B | 3.93B | 3.86B | 4.38B | 5.51B | 5.33B | 5.20B | 5.68B |
| Total assets | 29.11B | 32.92B | 34.46B | 36.31B | 36.82B | 36.25B | 37.10B | 36.66B |
| Total current liabilities | 5.03B | 5.51B | 4.23B | 6.33B | 5.31B | 6.50B | 4.79B | 6.39B |
| Short-term debt | 1.91B | 2.10B | 548.00M | 1.07B | 459.00M | 1.90B | 74.00M | 909.00M |
| Long-term debt | 7.96B | 9.83B | 10.79B | 8.28B | 7.86B | 7.61B | 9.71B | 7.92B |
| Total liabilities | 16,298,000,000.00 | 18,824,000,000.00 | 19,070,000,000.00 | 18,455,000,000.00 | 17,010,000,000.00 | 17,996,000,000.00 | 18,586,000,000.00 | 18,431,000,000.00 |
| Total equity | 12.81B | 14.09B | 15.39B | 17.85B | 19.81B | 18.26B | 18.51B | 18.23B |
| Retained earnings | 12.33B | 13.66B | 15.10B | 17.50B | 20.08B | 18.76B | 18.87B | 18.65B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 9.17B | 9.86B | 9.92B | 9.51B | 8.87B | 9.46B |
| Cash & ST investments | 992.00M | 1.55B | 1.23B | 1.28B | 500.00M | 740.00M |
| Inventory | 5.40B | 5.44B | 5.68B | 5.41B | 5.48B | 5.84B |
| Total assets | 36.28B | 36.46B | 36.66B | 36.02B | 35.17B | 35.61B |
| Total current liabilities | 5.49B | 5.69B | 6.39B | 6.20B | 4.85B | 6.60B |
| Short-term debt | 896.00M | 886.00M | 909.00M | 909.00M | 141.00M | 1.43B |
| Long-term debt | 8.17B | 8.18B | 7.92B | 7.45B | 7.94B | 6.58B |
| Total liabilities | 17,749,000,000.00 | 17,996,000,000.00 | 18,431,000,000.00 | 17,856,000,000.00 | 16,964,000,000.00 | 17,427,000,000.00 |
| Total equity | 18.53B | 18.47B | 18.23B | 18.16B | 18.20B | 18.19B |
| Retained earnings | 18.89B | 18.77B | 18.65B | 18.55B | 18.64B | 18.64B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.96B | 2.51B | 3.87B | 3.84B | 2.69B | 1.75B | 2.59B | 2.16B |
| Depreciation & amortization | 943.00M | 1.10B | 1.19B | 1.21B | 1.20B | 1.34B | 1.40B | 1.36B |
| Free cash flow | 1.76B | 1.25B | 2.68B | 2.63B | 800.00M | -187.00M | 1.46B | 1.18B |
| Dividends paid | -431.00M | -537.00M | -601.00M | -636.00M | -653.00M | -670.00M | -684.00M | -697.00M |
| Stock buybacks / issuance | -427.00M | -252.00M | -207.00M | -67.00M | -702.00M | -354.00M | -49.00M | -196.00M |
| Ending cash balance | 270.00M | 484.00M | 1.47B | 2.51B | 1.03B | 573.00M | 1.72B | 1.23B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -185.00M | 774.00M | 535.00M | 942.00M | -113.00M | 640.00M |
| Depreciation & amortization | 352.00M | 329.00M | 332.00M | 376.00M | 350.00M | 329.00M |
| Free cash flow | -378.00M | 547.00M | 248.00M | 690.00M | -258.00M | 481.00M |
| Dividends paid | -174.00M | -175.00M | -173.00M | -177.00M | -176.00M | -176.00M |
| Stock buybacks / issuance | -1.00M | -26.00M | -154.00M | -47.00M | -45.00M | -31.00M |
| Ending cash balance | 992.00M | 1.55B | 1.23B | 1.28B | 500.00M | 740.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 25.91 | 15.04 | 14.49 | 18.36 | 17.30 | -3.43 | 4.38 | 2.60 |
| ROA %i | 10.58 | 6.50 | 6.31 | 8.58 | 8.86 | -1.77 | 2.18 | 1.29 |
| ROIC %i | 15.08 | 9.86 | 9.50 | 12.49 | 12.74 | -1.21 | 3.92 | 2.62 |
| 5-year avg ROE %i | 17.19 | 17.86 | 18.06 | 18.09 | 18.03 | 12.25 | 10.17 | 7.87 |
| EBIT margin %i | 7.73 | 6.82 | 7.54 | 9.50 | 8.47 | -0.61 | 2.95 | 2.24 |
| FCF / sales %i | 4.40 | 2.96 | 6.19 | 5.59 | 1.50 | -- | 2.74 | 2.16 |
| Current ratioi | 1.13 | 1.27 | 1.79 | 1.55 | 1.81 | 1.34 | 2.04 | 1.55 |
| Quick ratioi | 0.40 | 0.48 | 0.80 | 0.78 | 0.68 | 0.47 | 0.86 | 0.59 |
| Debt / assetsi | 33.92 | 36.25 | 32.91 | 25.75 | 22.60 | 26.22 | 26.38 | 24.09 |
| LT debt / equityi | 62.19 | 70.47 | 70.74 | 46.72 | 39.90 | 41.97 | 52.82 | 43.80 |
| Interest coveragei | 8.84 | 6.26 | 6.71 | 10.44 | 12.37 | -0.91 | 3.27 | 2.71 |
| Revenue CAGR (3Y) %i | -1.08 | 4.76 | 4.12 | 5.51 | 7.91 | 6.98 | 4.25 | 0.72 |
| Net income CAGR (3Y) %i | 34.52 | 3.85 | 5.13 | 0.86 | 17.82 | -- | -35.97 | -47.30 |
| FCF CAGR (3Y) %i | 0.90 | -14.71 | 20.47 | 14.28 | -13.91 | -- | -17.86 | 13.74 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 5.01 | 4.31 | 2.60 | 1.10 | 2.48 | 3.15 |
| ROA %i | 2.48 | 2.11 | 1.29 | 0.55 | 1.27 | 1.59 |
| ROIC %i | 4.28 | 3.72 | 2.62 | 1.74 | 2.57 | 3.13 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 3.23 | 3.05 | 2.24 | 1.54 | 2.09 | 2.20 |
| FCF / sales %i | 2.39 | 2.40 | 2.16 | 2.01 | 2.20 | 2.08 |
| Current ratioi | 1.67 | 1.73 | 1.55 | 1.53 | 1.83 | 1.43 |
| Quick ratioi | 0.61 | 0.70 | 0.59 | 0.60 | 0.60 | 0.48 |
| Debt / assetsi | 24.99 | 24.86 | 24.09 | 23.22 | 22.99 | 22.48 |
| LT debt / equityi | 44.41 | 44.60 | 43.80 | 41.35 | 43.88 | 36.39 |
| Interest coveragei | 3.50 | 3.49 | 2.71 | 1.97 | 2.78 | 3.02 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Beef is the largest reported line at 38.87% of revenue, across 6 reported segments.
- No single line clears half of revenue; Chicken is next at 30.68%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Beef38.87%
Chicken30.68%
Prepared foods18.44%
Pork11.39%
International4.33%
Quote time 2026-10-08 08:26:02 · For reference only, not investment advice and not tailored to your situation.